1. 53PImmune-related adverse events correlate with clinical outcomes in non-small cell lung cancer (NSCLC) patients treated with nivolumab in the Italian expanded access programme. (17th December 2018) Authors: Baldini, E; Lunghi, A; Cortesi, E; Turci, D; Garassino, M C; Stati, V; Ardizzoni, A; Ricciuti, B; Frassoldati, A; Romano, G; Illiano, A; Verderame, F; Fasola, G; Marchetti, P; Pinto, C; Carteni, G; Scotti, V; Tibaldi, C; Fioretto, L; Giannarelli, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Issue 11 (November 2021) Authors: Glasbey, James; Ademuyiwa, Adesoji; Adisa, Adewale; AlAmeer, Ehab; Arnaud, Alexis P; Ayasra, Faris; Azevedo, José; Minaya-Bravo, Ana; Costas-Chavarri, Ainhoa; Edwards, John; Elhadi, Muhammed; Fiore, Marco; Fotopoulou, Christina; Gallo, Gaetano; Ghosh, Dhruva; Griffiths, Ewen A; Harrison, Ewen; H... Journal: Lancet oncology Issue: Volume 22:Issue 11(2021) Page Start: 1507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LBA54IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC). (23rd October 2018) Authors: Barlesi, F; Nishio, M; Cobo, M; Steele, N; Paramonov, V; Parente, B; Dear, R; Berard, H; Peled, N; Seneviratne, L C; Baldini, E; Watanabe, S; Goto, K; Mendus, D; Patel, H; Deng, Y; Kowanetz, M; Hoang, T; Lin, W; Papadimitrakopoulou, V A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗